Woodline Partners’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,537,433
| Closed | -$5.77M | – | 638 |
|
|
2024
Q1 | $5.77M | Sell |
1,537,433
-316,674
| -17% | -$1.19M | 0.05% | 343 |
|
|
2023
Q4 | $18.2M | Sell |
1,854,107
-527,600
| -22% | -$5.18M | 0.2% | 155 |
|
|
2023
Q3 | $19.9M | Buy |
2,381,707
+1,580,570
| +197% | +$13.2M | 0.23% | 131 |
|
|
2023
Q2 | $10.7M | Buy |
801,137
+193,203
| +32% | +$2.57M | 0.13% | 202 |
|
|
2023
Q1 | $7.04M | Buy |
+607,934
| New | +$7.04M | 0.1% | 243 |
|